Purchase our hematology module on a standalone basis or together with other modules and solutions across our full portfolio to create an integrated, tailor-made research platform.
Blood diseases, including blood cancers and bleeding disorders, such as hemophilia, constitute some of the most life-threatening diseases.
Although significant progress has been made over the past two decades, it has come at the cost of increasingly complex disease managements. This is particularly true with blood cancers (leukemia, lymphoma and lymphoid malignancies) as treatments now include multiple lines of therapies (induction, consolidation and maintenance) and diverse approaches, such as intensive vs non-intensive chemotherapy and eligibility for stem cell transplants.
As GlobalData analysts for hematology are also experts in oncology, they are skilled to identify the opportunities and unmet needs that will drive the market in such a fragmented and complex environment.
Our therapy module includes coverage of disorders such as hemophilia and anemia, among others.